SRTA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -31.11. Updated 2026-07-23.
Strata Critical Medical (SRTA) Research Hub
Strata Critical Medical (SRTA) trades on NASDAQ, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-09-11, shares last closed at 5.195 USD (-0.48%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -31.11, market cap 0.44B. This hub links to the full technical, earnings and options research available for SRTA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.195 USD (-0.48%) |
| 52-week range | 4.86 USD – 6.29 USD |
| Trend regime | Range |
| 14-day RSI | 33.2 (Bearish) |
| Trailing P/E | -31.11 |
| Market cap | 0.44B |
| Dividend yield | 0.00% |
Available research for SRTA
Covered Call on SRTA: how it works, illustrative setup around the real 5.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SRTA: how it works, illustrative setup around the real 5.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SRTA: how it works, illustrative setup around the real 5.2 USD price, max profit/loss, breakeven and when to use it. Educational.
SRTA technical analysis: range, last 5.195 USD, RSI 33.2, 52w range 4.86 USD–6.29 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SRTA in?
Strata Critical Medical (SRTA) is classified under Healthcare (Medical - Care Facilities), listed on NASDAQ, US.
Is SRTA in an uptrend or downtrend?
As of 2026-09-11, SRTA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SRTA's trailing P/E ratio?
SRTA's trailing P/E is -31.11, with a market cap of 0.44B. See the earnings research page for full valuation detail.